JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9%
Thu, 31 Oct

JUBILANT LIFE SCIENCES has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

JUBILANT LIFE SCIENCES Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m22,69521,81922,6593.9%-0.2%
Other incomeRs m389712326.4%220.1%
TurnoverRs m22,73321,91622,7824.0%0.2%
ExpensesRs m18,19317,47317,9752.9%-1.2%
Gross profitRs m4,5024,3464,6857.8%4.1%
DepreciationRs m8951,0271,16813.8%30.6%
InterestRs m627726716-1.3%14.2%
Profit before taxRs m3,0182,6902,9228.6%-3.2%
TaxRs m920841428-49.0%-53.5%
Profit after taxRs m2,0981,8502,49434.8%18.9%
Gross profit margin%19.819.920.7
Effective tax rate%30.531.214.7
Net profit margin%9.28.410.9
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 0.2% on a year-on-year (YoY) basis. The expenses were down by 1.2% YoY during the same period.
  • The company's operating profit increased by 4.1% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.7% in 2QFY20 as against 19.8% in 2QFY19.
  • Depreciation charges increased by 30.6% and finance costs increased by 14.2% YoY, respectively.
  • Other income increased by 220.1% YoY during the quarter.
  • Net profit for the quarter increased by 18.9% YoY. Net profit margins during the quarter increased from 9.2% in 2QFY19 to 10.9% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 3.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 2.9% QoQ during the same period.
  • The company's operating profit increased by 7.8% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.7% in 2QFY20 as against 19.9% in 1QFY19.
  • Net profit for the quarter increased by 34.8% QoQ, while net profit margins increased from 8.4% in 1QFY19 to 10.9% in 2QFY20.

To see how JUBILANT LIFE SCIENCES has performed over the last eight quarters,please visit here.

REVEALED: Brijesh Bhatia's Private Telegram Channel (JOIN NOW)

JUBILANT LIFE SCIENCES Share Price Performance

Over the last one year,JUBILANT LIFE SCIENCES share price has moved down from Rs 661.5 to Rs 547.1, registering a Loss of Rs 114.5 or around 17.3%.

Meanwhile, the S&P BSE OIL & GAS Index is trading at Rs 15,741.0 (up 0.6%). Over the last one year it has moved up from 13,246.9 to 15,741.0, a gain of 2,494 points (up 18.8%).

Overall, the S&P BSE SENSEX is up 18.7% over the year.

Current Valuations

At the current price of Rs 547.1, the price to earnings (P/E) ratio of JUBILANT LIFE SCIENCES stands at 14.5 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.8 times.

Equitymaster requests your view! Post a comment on "JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9%". Click here!

  

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

These Are the Best Stocks to Own(Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

The Road to 100 Baggers Begins Here(Profit Hunter)

Jul 22, 2021

How to be an early investor in future 100 baggers.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying(Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Aug 3, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 5-YR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS